Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | STK17B | O94768 | 6/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 3/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29707476 | 1.00 | PKM (0.54) | PKMTSHRSTK17BMEN1KMT2A | |
| SCHEMBL8466712 | 0.92 | PKM (0.52) | PKMTSHRSTK17BMEN1KMT2A | |
| Dimethyl Sulfoxide SCHEMBL29085605 | 0.87 | STK17B (0.44) | PKMTSHRSTK17BMEN1KMT2A | |
| SCHEMBL167093 | 0.83 | — | — | |
| SCHEMBL12691224 | 0.83 | TDP1 (0.63) | PKMTSHRSTK17BMEN1KMT2A | |
| SCHEMBL19754922 | 0.83 | TDP1 (0.63) | PKMTSHRSTK17BMEN1KMT2A | |
| SCHEMBL30320031 | 0.83 | TDP1 (0.63) | PKMTSHRSTK17BMEN1KMT2A | |
| Acrylic Acid SCHEMBL31497014 | 0.82 | STK17B (0.49) | PKMTSHRSTK17BMEN1KMT2A | |
| SCHEMBL13397579 | 0.81 | STK17B (0.47) | PKMTSHRSTK17BMEN1KMT2A | |
| SCHEMBL3261837 | 0.80 | STK17B (0.50) | PKMTSHRSTK17BMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120137268-A | Carboxymethyl cellulose-ionic liquid-conductive polymer film and preparation method and application thereof | 南京理工大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119230299-A | Solid-state capacitor and preparation method thereof | 聚镕光电(广州)新材料科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| EP-3303312-B1 | PROCESS FOR PREPARING (E)-(5,6-DIHYDRO-1,4,2-DIOXAZINE-3-YL)(2-HYDROXYPHENYL)METHANONE O-METHYL OXIME | ARYSTA LIFESCIENCE CORP (JP) | 2023-07-19 | — | — | EP | claimed |
| US-20220154222-A1 | NOVEL NUCLEIC ACID MODIFIERS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2022-05-19 | — | — | US | claimed |
| CN-109153773-B | Ladder-type polybenzobifurans | 国际商业机器公司 | 2021-02-26 | — | — | CN | claimed |
| WO-2020186213-A1 | NOVEL NUCLEIC ACID MODIFIERS | THE BROAD INSTITUTE, INC. (US) | 2020-09-17 | — | — | WO | claimed |
| EP-3699178-A1 | PROCESS FOR PREPARING FLUOXASTROBIN | Arysta LifeScience Corporation (JP) | 2020-08-26 | — | — | EP | claimed |
| EP-3019495-B1 | PROCESS FOR PREPARING FLUOXASTROBIN | ARYSTA LIFESCIENCE CORP (JP) | 2020-06-03 | — | — | EP | claimed |
| CN-109689060-A | combination chemotherapy | 系统肿瘤学有限公司 | 2019-04-26 | — | — | CN | claimed |
| US-10087152-B2 | Process for preparing (E)-(5,6-dihydro-1,4,2-dioxazin-3-yl)(2-hydroxyphenyl)methanone O-methyl oxime | ARYSTA LIFESCIENCE CORPORATION (JP) | 2018-10-02 | — | — | US | claimed |
| US-6479675-B1 | Processes for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl) dioxazines | BAYER AKTIENGESELLSCHAFT (DE) | 2002-11-12 | — | — | US | claimed |
| US-6472498-B2 | COLORLESS | UBE INDUSTRIES, LTD. (JP) | 2002-10-29 | — | — | US | claimed |
| CN-1343207-A | Benzofuran-2-ones as colorants for organic materials | CIBA SC HOLDING AG (CH) | 2002-04-03 | — | — | CN | claimed |
| US-20020019512-A1 | Diaryl carbonate product and production of polycarbonate | UBE INDUSTRIES, LTD. | 2002-02-14 | — | — | US | claimed |
| EP-1178033-A1 | Process for the purification of diaryl carbonate and process for the production of polycarbonate | Ube Industries, Ltd. (JP) | 2002-02-06 | — | — | EP | claimed |
| EP-1159276-A2 | BENZOFURAN-2-ONES AS COLORANTS FOR ORGANIC MATERIALS | Ciba SC Holding AG (CH) | 2001-12-05 | — | — | EP | claimed |
| US-6150521-A | Process for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl) dioxazines | BAYER AKTIENGESELLSCHAFT (DE) | 2000-11-21 | — | — | US | claimed |
| WO-2000053597-A2 | BENZOFURAN-2-ONES AS COLORANTS FOR ORGANIC MATERIALS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-09-14 | — | — | WO | claimed |
| EP-0670841-B1 | AMORPHOUS SOLID MODIFICATION OF 2,2',2''-NITRILO TRIETHYL-TRIS-(3,3',5,5'-TETRA-TERT-BUTYL-1,1'-BIPHENYL-2,2'-DIYL)PHOSPHITE] | CIBA GEIGY AG (CH) | 1997-01-22 | — | — | EP | claimed |
| US-4385006-A | Process for preparing aromatic nitriles | 501 SOCIETE FRANCAISE HOECHST (FR) | 1983-05-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019512-A1 | Diaryl carbonate product and production of polycarbonate | PKD1, APC, PKD2 | PKM 2826/4885TSHR 4819/4885STK17B 3574/4885 |
| US-10087152-B2 | Process for preparing (E)-(5,6-dihydro-1,4,2-dioxazin-3-yl)(2-hydroxyphenyl)methanone O-methyl oxime | HMOX2, HAO2, HMOX1 | PKM 1721/4885TSHR 3439/4885STK17B 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.